Brain Advance Access originally published online on August 2, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 127, No. 9, 1928-1941,
September 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh217
Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination
1 Cambridge Centre for Brain Repair and Centre for Veterinary Sciences, University of Cambridge, UK and 2 Institute of Cell Biology, ETH Zürich, Switzerland
Correspondence to: Dr Robin Franklin, The Veterinary School, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK E-mail: rjf1000{at}cam.ac.uk
The reasons for the eventual failure of repair mechanisms in multiple sclerosis are unknown. The presence of precursor and immature oligodendrocytes in some non-repairing lesions suggests a mechanism in which these cells either receive insufficient differentiation signals or are exposed to differentiation inhibitors. Jagged signalling via Notch receptors on oligodendrocyte precursor cells (OPCs) inhibits their differentiation during development and the finding that both notch and jagged are expressed in multiple sclerosis lesions has fostered the view that this signalling pathway may explain remyelination failure. In this study, we show that Notch1 is expressed on adult OPCs and that there are multiple cellular sources of its ligand Jagged1 in a rodent model of remyelination. However, despite their expression, the lesions undergo complete remyelination. To establish whether Notch-jagged signalling regulates the rate of remyelination we compared their expression profiles in young animals with those in older animals, where remyelination occurs more slowly, but could find no correlation between expression and remyelination rate. Finally we found that OPC-targeted Notch1 ablation in cuprizone-treated Plp-creER Notch1lox/lox transgenic mice yielded no significant differences in remyelination parameters between knock-out and control mice. Thus, in contrast to developmental myelination, adult expression of Notch1 and Jagged1 neither prevents nor plays a major rate-determining role in remyelination. More generally, the re-expression of developmentally expressed genes following injury in the adult does not per se imply similar function.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Einstein, Y. Friedman-Levi, N. Grigoriadis, and T. Ben-Hur Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration J. Neurosci., December 16, 2009; 29(50): 15694 - 15702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, A. T. Argaw, B. T. Gurfein, A. Zameer, B. J. Snyder, C. Ge, Q. R. Lu, D. H. Rowitch, C. S. Raine, C. F. Brosnan, et al. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination PNAS, November 10, 2009; 106(45): 19162 - 19167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Baer, Y. A. Syed, S. U. Kang, D. Mitteregger, R. Vig, C. ffrench-Constant, R. J. M. Franklin, F. Altmann, G. Lubec, and M. R. Kotter Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling Brain, February 1, 2009; 132(2): 465 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kessaris, N. Pringle, and W. D Richardson Specification of CNS glia from neural stem cells in the embryonic neuroepithelium Phil Trans R Soc B, January 12, 2008; 363(1489): 71 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Elyaman, E. M. Bradshaw, Y. Wang, M. Oukka, P. Kivisakk, S. Chiba, H. Yagita, and S. J. Khoury Jagged1 and Delta1 Differentially Regulate the Outcome of Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 2007; 179(9): 5990 - 5998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Herrero-Herranz, L. A. Pardo, G. Bunt, R. Gold, W. Stuhmer, and R. A. Linker Re-Expression of a Developmentally Restricted Potassium Channel in Autoimmune Demyelination: Kv1.4 Is Implicated in Oligodendroglial Proliferation Am. J. Pathol., August 1, 2007; 171(2): 589 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lin, A. Kemper, J. L. Dupree, H. P. Harding, D. Ron, and B. Popko Interferon-{gamma} inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress Brain, May 1, 2006; 129(5): 1306 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Imitola, T. Chitnis, and S. J. Khoury Insights Into the Molecular Pathogenesis of Progression in Multiple Sclerosis: Potential Implications for Future Therapies Arch Neurol, January 1, 2006; 63(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|